Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.
Also called NCT05928936
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose basic science
- Phase
- Phase 2
- Enrolled
- 156 participants
- Registry
-
NCT05928936
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05928936. Randomized; quadruple masking; primary purpose basic science. Start 2022-11-11 (actual); primary completion 2028-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- Sodium Bicarbonate
- Intervention (Behavioral)
- Exercise Training
- Intervention (Drug)
- Placebo
- Lead sponsor
- Emory University
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct05928936- Content hash
cba2778f0ed3cb621e6c38db425a672db165e00ca67a83f4acf002b82b49f789